Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (157)	1/5/2007 4:30:52 PM
From: BulbaMan	Read Replies (2) \| Respond to of 397

Here are all the Contest stock picks and the number of contestants picking each stock: ARNA 12 MNTA 12 MEDX 10 COLY 9 EXEL 8 COR 6 IDIX 6 BCRX 5 DVAX 5 GNVC 5 KOSN 5 BMRN 4 CYTK 4 MAXY 4 MBRX 4 MLNM 4 NBIX 4 NURO 4 PCOP 4 RNVS 4 SEPR 4 ACAD 3 ALXN 3 ARQL 3 CRGN 3 CRIS 3 CRME 3 DSCO 3 ELN 3 KERX 3 MOGN 3 NRGN 3 NTII 3 RIGL 3 RPRX 3 SPPI 3 ANDS 2 ASPV 2 AVGN 2 CALP 2 CVTX 2 DNDN 2 ENCY 2 EPIX 2 GENT 2 GERN 2 GLGC 2 KDUS.OB 2 MYGN 2 NKTR 2 PPHM 2 SGXP 2 SNUS 2 SOMX 2 TPTX 2 VICL 2 ACM.L 1 ACUS 1 ADLR 1 ADZA 1 AFFX 1 AGIX 1 ALNY 1 ALTH 1 ALXA 1 AMLN 1 AMRI 1 ANPI 1 ANX 1 ARRY 1 AVNC 1 BIVN 1 BJCT 1 BJGP 1 BVF 1 CBST 1 CDTP.OB 1 CELG 1 CEPH 1 CHTP 1 CRXL 1 CTIC 1 CYCC 1 CYPB 1 DCGN 1 DRRX 1 DVSA 1 DYAX 1 GHDX 1 GILD 1 GIVN 1 GNLB 1 GPCB 1 HGSI 1 IDEV 1 IDP 1 IEX.TO 1 ILMN 1 IMM 1 INCY 1 ISA.TO 1 ISIS 1 ITMN 1 MDCO 1 MDG.DE 1 MEMY 1 NFLD 1 ONXX 1 OPXA 1 PA8.F 1 PANC 1 PCYC 1 PDLI 1 POSS 1 POTP 1 POZN 1 PTDX.L 1 PTIE 1 REGN 1 RENE.L 1 RNVO.L 1 SCLN 1 SGEN 1 SPPN.SW 1 SQNM 1 SRDX 1 STEM 1 STXS 1 TH.TO 1 THRX 1 TRMS 1 VASC 1 VER.L 1 VPHM 1 VRTX 1 VVUS 1 XOMA 1 YMI 1

To: BulbaMan who wrote (157)	1/6/2007 9:52:01 AM
From: Biotech Jim	Read Replies (1) \| Respond to of 397

Since I have received several queries as to my involvement in the charity contest this year, I am submitting this public reply to inform that I will not be participating due to professional reasons. I will contribute to the winner's charity however, to the tune of $200. My general thoughts on the sector are that product stage antibody companies should do well or get bought out, and emergent pipeline small molecule biotechs will do well also. Platform companies without meaningful pipelines will continue to underperform. Look for a continuing stringent FDA, which will be apparent in the increasing competitive oncology space. Bj